Nathan Connell on the 1st von Willebrand Factor/Factor VIII Relevance Academy
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared on LinkedIn:
”We recently held the first von Willebrand Factor/Factor VIII Relevance Academy in Orlando, Florida.
It was a wonderful day of learning and discussion about so many topics of importance to the hemostasis community.
From basic science to clinical and epidemiologic applications, I was excited to see so much focus on improving the quality of life for those with inherited bleeding disorders.
I was asked to present on the role of VWF concentrate prophylaxis in people with von Willebrand disease.
We have more data now than we did when the international VWD guidelines were published in 2021.
Still, we continue to have so many questions about who would benefit the most and how to optimize our prophylaxis strategies.
Thank you to the always outstanding Octapharma team, including Stefano Carta, Belyanskaya Larisa, Claudio Sandoval, and many others, as well as Academy chair Robert Sidonio, and all the faculty and participants who contributed to the discussion.”
Stay updated with Hemostasis Today.
-
Dec 10, 2025, 17:22In the Fight for Hematology: Adetokunbo O’s Reflections from ASH25
-
Dec 10, 2025, 17:11Driving Innovation in Rare Blood Disorders: Jeff Schaffnit’s ASH 2025 Perspective
-
Dec 10, 2025, 16:37Arthur Allen – The New President-Elect of the Anticoagulation Forum Board of Directors
-
Dec 10, 2025, 16:29Matthew D Neal: An Oasis in the Platelet Desert?
-
Dec 10, 2025, 16:14Yashpal Singh Rawat: Fortis Memorial Research Institute Made Its Positive Mark at ASH
-
Dec 10, 2025, 14:57Elvira Grandone Announces the 1st ThrombUS+ Data Challenge
-
Dec 10, 2025, 14:18Love Preet Kalra on A Paradigm Shift in ICH
-
Dec 10, 2025, 13:37Aakanksha A: A Highlight of the Week Was Presenting Our ASH Poster
-
Dec 9, 2025, 23:37Thomas Reiser: Renew Your ISTH Membership for 2025